| 000 | 01608 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516045427.0 | ||
| 264 | 0 | _c20120201 | |
| 008 | 201202s 0 0 eng d | ||
| 022 | _a1524-4741 | ||
| 024 | 7 |
_a10.1111/j.1524-4741.2011.01119.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aQuispe, Dolly | |
| 245 | 0 | 0 |
_aOsteonecrosis of the jaw in patients with metastatic breast cancer: ethnic and socio-economic aspects. _h[electronic resource] |
| 260 |
_bThe breast journal _c |
||
| 300 |
_a510-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBlack or African American |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBisphosphonate-Associated Osteonecrosis of the Jaw _xethnology |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPamidronate |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSmoking |
| 650 | 0 | 4 | _aSocioeconomic Factors |
| 650 | 0 | 4 | _aWhite People |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aShi, Runhua | |
| 700 | 1 | _aBurton, Gary | |
| 773 | 0 |
_tThe breast journal _gvol. 17 _gno. 5 _gp. 510-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1524-4741.2011.01119.x _zAvailable from publisher's website |
| 999 |
_c21009835 _d21009835 |
||